Many more structures and assays flesh out additional details in the paper, so dig in! Major team effort from collaborators above, Young-jun Park William Glass Ivy Zhang @johnbowenbio Julia di Iulio Tristan Croll @atelentia Florian Lempp and many twitter-less

BREAKING NEWS: Vir, in partnership with GSK, has received Emergency Use Authorization from the U.S. FDA for our investigational monoclonal antibody for the treatment of mild-to-moderate #COVID19. bit.ly/3i98ULx

Our covid times :-)

Science tells us that most Americans do not need a COVID-19 vaccine booster (1/3) 1. With time, vaccine-induced antibodies wane but the same happens with all vaccines and infections.

Looking for a Scientist to join our virology team at Vir Biotechnology and help develop novel antiviral therapies. Please share. jobs.lever.co/vir/7a90613d-2…

A paper in Nature shows that three C-type lectin receptors function as viral entry enhancing attachment receptors for SARS-CoV-2 and that the neutralizing properties of some antibodies are modulated by the expression of these lectins. go.nature.com/38sSLKQ

📢 Job alert (please RT): my lab is looking for a PhD-level scientist to join us Chan Zuckerberg Biohub Network. We study virus-host interactions across different viral families using a combination of CRISPR/base editing screens, molecular virology and cell bio methods. apply.workable.com/j/97E9644F5A/?…

Pretty neat overview: Visual Capitalist: Visualizing the World's Biggest Pharmaceutical Companies. visualcapitalist.com/worlds-biggest…

20 productivity hacks that will change your life: A thread:

We are looking for an Associate Director level clinical immunologist to join our Biomarker group at VIR. Come join an incredible team working to bring new therapeutics to respiratory viral pathogens, including SARS-CoV-2 and Influenza. #hiring #immunology jobs.lever.co/vir/b607120e-5…

Point-of-care HDV test could help alleviate the high cost of current testing, leading to more HDV screening: Florian Lempp #hdv #hepd #hbv #hepb #hepatitisd #hepatitisb #hepatitis #hepatitisdelta #hepdelta mdpi.com/1999-4915/13/1…

Vir is excited for EASLnews #ILC2022. We will join the Hepatitis Delta International Network meeting today, and present new #HBV data on June 25. We are taking a bold approach to developing new therapies intended to support millions of patients with significant unmet needs.

Vir is pleased to announce we have been awarded a BARDA contract with an initial investment of approx. $55M, which also allows for potential total investment of up to $1B, to support pandemic preparedness for influenza/other infectious disease threats. tinyurl.com/a6nnzbm3

Check out recent research led by Vir scientists Michael A. Schmid and Florian Lempp on a unique monoclonal antibody (mAb) that aims to fight chronic hepatitis B and D infections (HBV/HDV) by reducing circulating HBsAg and viremia: 1/4

Great gala by the Hep B Foundation to celebrate a year of progress against #HBV. Congratulations to honorees Prof. Stephan Urban, Ph.D., and Su Wang, M.D., M.P.H. (HepB Cant Wait)! Let's keep raising awareness and working to protect lives.

We are looking for two SRAs in Virology with focus on HIV or HBV. If you have experience in cell culture/mol. bio, and are passionate to develop therapies against infectious diseases, check out these job opportunities. Located in our beautiful SF/Mission Bay HQ. Links below 👇

Identification of a human mAb VIR-3434 that potently neutralizes #HBV and #HDV 🔗journal-of-hepatology.eu/article/S0168-… Florian Lempp #OpenAccess #LiverTwitter

ICE-HBV member Thomas Tu (Thomas Tu) is a finalist for the Coles People's Choice Award at the 2024 Sydney Awards! 🌟👏 Support his vital work as a #hepatitisB scientist, advocate, and community member. 👉 Vote here: sydney.org.au/c/sydney-award… Your vote can make a difference! 🗳️